ID   NCCSEDi001-A-1
SY   NANS-2-6
DR   BioSamples; SAMEA7222556
DR   hPSCreg; NCCSEDi001-A-1
DR   Wikidata; Q105510307
RX   PubMed=33130469;
CC   From: National Chengdu Center for Safety Evaluation of Drugs; Chengdu; China.
CC   Population: Chinese; Han.
CC   Characteristics: Using CRISPR/Cas9 GFP-P2A-Puro was integrated in both alleles of NANS exon 1 (PubMed=33130469).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 19237; NANS.
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 6
RX   PubMed=33130469; DOI=10.1016/j.scr.2020.102052;
RA   Bu Q., Zhang H.-Q., Liu Q., Dai Y.-P., Wei Q., Xue A.-Q., Huang Y.,
RA   Zhong K., Huang Y.-N., Gao H., Cen X.-B.;
RT   "Generation of an NANS homozygous knockout human induced pluripotent
RT   stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9
RT   editing.";
RL   Stem Cell Res. 49:102052-102052(2020).